Ardelyx (ARDX) Depreciation and Depletion (2014 - 2022)
Ardelyx (ARDX) reported Depreciation and Depletion of $175000.0 for Q2 2022, down 52.05% on a YoY basis from $365000.0 in Q2 2021, and down 24.57% quarter-over-quarter from $232000.0 in Q1 2022.
Ardelyx (ARDX) Depreciation and Depletion (2014 - 2022) Analysis & Trends
Ardelyx has reported Depreciation and Depletion for 9 years, with the latest figure at $175000.0 in Q2 2022.
- For the quarter ending Q2 2022, Depreciation and Depletion fell 52.05% year-over-year to $175000.0; the trailing twelve-month figure through Jun 2022 stood at $1.0 million (down 37.31% YoY), and the FY2025 full-year result was $800000.0, up 60.0% from the prior year.
- Depreciation and Depletion for Q2 2022 stood at $175000.0, down from $232000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $678000.0 in Q2 2019, with the low at $153000.0 in Q4 2021.
- Historically, Depreciation and Depletion has averaged $488111.1 across 5 years, with a median of $480000.0 in 2020.
- Annual changes were most pronounced in 2018 — Depreciation and Depletion grew 13.47% — and 2021, when it tumbled 61.85%.
- Ardelyx's Depreciation and Depletion stood at $673000.0 in 2018, then fell by 24.52% to $508000.0 in 2019, then decreased by 21.06% to $401000.0 in 2020, then plunged by 61.85% to $153000.0 in 2021, then grew by 14.38% to $175000.0 in 2022.
- The last three Depreciation and Depletion figures came in at $175000.0 (Q2 2022), $232000.0 (Q1 2022), and $153000.0 (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 175,000.00 |
| Mar 31, 2022 | 232,000.00 |
| Mar 31, 2022 | 232,000.00 |
| Dec 31, 2021 | 153,000.00 |
| Dec 31, 2021 | 153,000.00 |
| Sep 30, 2021 | 460,000.00 |
| Sep 30, 2021 | 460,000.00 |
| Jun 30, 2021 | 365,000.00 |
| Jun 30, 2021 | 365,000.00 |
| Mar 31, 2021 | 422,000.00 |
| Mar 31, 2021 | 422,000.00 |
| Dec 31, 2020 | 401,000.00 |
| Dec 31, 2020 | 401,000.00 |
| Sep 30, 2020 | 439,000.00 |
| Sep 30, 2020 | 439,000.00 |
| Jun 30, 2020 | 468,000.00 |
| Jun 30, 2020 | 468,000.00 |
| Mar 31, 2020 | 492,000.00 |
| Mar 31, 2020 | 492,000.00 |